Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Ovarian Cancer Excellence Forum

Ovarian Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Rebekah Peplinski, graduate research assistant and PhD candidate, University of Iowa, Iowa City, Iowa
Videos
Identifying Oncogenic Drivers Related to Tumor Progression in High-Grade Ovarian Cancer
05/08/2023
At the SGO Annual Meeting on Women’s Cancer, Rebekah Peplinski, PhD candidate, discusses the potential role of Sleeping Beauty mutagenesis for identifying and understanding genes related to tumor progression in high-grade ovarian cancer.
At the SGO Annual Meeting on Women’s Cancer, Rebekah Peplinski, PhD candidate, discusses the potential role of Sleeping Beauty mutagenesis for identifying and understanding genes related to tumor progression in high-grade ovarian cancer.
At the SGO Annual Meeting on...
05/08/2023
Oncology
Jung-Yun Lee, MD, Yonsei University
Videos
Durvalumab Plus Tremelimumab Added to Frontline Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
03/30/2023
Jung-Yun Lee, MD, discusses the final primary analysis from a phase 2 study that explored durvalumab plus tremelimumab added to frontline neoadjuvant chemotherapy for patients with advanced ovarian cancer.
Jung-Yun Lee, MD, discusses the final primary analysis from a phase 2 study that explored durvalumab plus tremelimumab added to frontline neoadjuvant chemotherapy for patients with advanced ovarian cancer.
Jung-Yun Lee, MD, discusses the...
03/30/2023
Oncology
Brian Slomovitz, MD, Mount Sinai Medical Center, Miami, FL
Videos
Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Cancer
03/26/2023
Brian Slomovitz, MD, discusses his presentation on the use of letrozole plus ribociclib for patients with recurrent low-grade serous carcinoma of the ovaries at the SGO Annual Meeting on Women's Cancer.
Brian Slomovitz, MD, discusses his presentation on the use of letrozole plus ribociclib for patients with recurrent low-grade serous carcinoma of the ovaries at the SGO Annual Meeting on Women's Cancer.
Brian Slomovitz, MD, discusses...
03/26/2023
Oncology
Oliver Zivanovic, MD, Memorial Sloan Kettering Cancer Center
Videos
In Support of HIPEC as Standard of Care for Stage 3 Ovarian Cancer
11/30/2022
Oliver Zivanovic, MD, defends HIPEC as standard of care treatment for patients with ovarian cancer, a topic he presented at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Oliver Zivanovic, MD, defends HIPEC as standard of care treatment for patients with ovarian cancer, a topic he presented at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Oliver Zivanovic, MD, defends...
11/30/2022
Oncology
Kathleen Moore, MD
Videos
Current and Emerging Therapies for Platinum-Resistant Ovarian Cancer
11/15/2022
Kathleen Moore, MD, gives an overview on recent developments in treatments for advanced stage ovarian cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
Kathleen Moore, MD, gives an overview on recent developments in treatments for advanced stage ovarian cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.
Kathleen Moore, MD, gives an...
11/15/2022
Oncology
Carrie Langstraat, MD
Videos
HIPEC: Standard of Care for Ovarian Cancer?
11/08/2022
Carrie Langstraat, MD, discusses whether HIPEC should be considered the standard of care for ovarian cancer, a subject she debated at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Carrie Langstraat, MD, discusses whether HIPEC should be considered the standard of care for ovarian cancer, a subject she debated at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.
Carrie Langstraat, MD, discusses...
11/08/2022
Oncology
Janos L Tanyi, MD
Videos
Pafolacianine to Detect Folate Receptor-Positive Ovarian Cancer
10/12/2022
Janos Tanyi, MD, shares results and insights from the phase 3 to confirm the safety and efficacy of pafolacianine for the detection of folate receptor-positive ovarian cancer.
Janos Tanyi, MD, shares results and insights from the phase 3 to confirm the safety and efficacy of pafolacianine for the detection of folate receptor-positive ovarian cancer.
Janos Tanyi, MD, shares results...
10/12/2022
Oncology
Robert Coleman, MD, Texas Oncology, US Oncology Network
Videos
Rucaparib Maintenance Reduces Risk of Disease Progression in Platinum-Sensitive Ovarian Cancer
06/22/2022
Robert Coleman, MD, discusses findings from a post hoc exploratory analysis of the ARIEL3 trial, which further evaluated the efficacy and safety of rucaparib maintenance in patients with platinum-sensitive, recurrent ovarian carcinoma who are...
Robert Coleman, MD, discusses findings from a post hoc exploratory analysis of the ARIEL3 trial, which further evaluated the efficacy and safety of rucaparib maintenance in patients with platinum-sensitive, recurrent ovarian carcinoma who are...
Robert Coleman, MD, discusses...
06/22/2022
Oncology
David O'Malley
Podcasts
Part 2: Overcoming PARP Inhibitor and Platinum Resistance in Patients With Ovarian Cancer
06/20/2022
In part 2 of this 2-part podcast series, David O'Malley, MD, Ohio State University, discusses strategies for overcoming PARP inhibitor and platinum resistance in patients with ovarian cancer.
In part 2 of this 2-part podcast series, David O'Malley, MD, Ohio State University, discusses strategies for overcoming PARP inhibitor and platinum resistance in patients with ovarian cancer.
In part 2 of this 2-part podcast...
06/20/2022
Oncology
Robert Coleman, MD, Texas Oncology, US Oncology Network
Videos
First-Line Rucaparib Maintenance Effective for Ovarian Cancer: ATHENA-MONO Trial
06/20/2022
Robert Coleman, MD, discusses findings from the phase 3 ATHENA-MONO trial which compared rucaparib vs placebo for maintenance therapy in patients with advanced-stage ovarian cancer.
Robert Coleman, MD, discusses findings from the phase 3 ATHENA-MONO trial which compared rucaparib vs placebo for maintenance therapy in patients with advanced-stage ovarian cancer.
Robert Coleman, MD, discusses...
06/20/2022
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement